Used primarily in the treatment of Parkinson’s disease, this compound acts as a dopamine agonist, helping to manage motor symptoms such as tremors, stiffness, and slowed movement. It targets dopamine D2 and D3 receptors in the brain, supporting nerve signaling involved in movement control. Due to its active metabolite profile, it contributes to prolonged dopaminergic stimulation, which can improve symptom consistency throughout the day. It may also be investigated for use in restless legs syndrome, where dopamine regulation plays a key role in reducing uncomfortable sensations and the urge to move the limbs, especially during rest.